Acuren [TIC] vs Cintas [CTAS] Detailed Stock Comparison
Acuren
NYSE
Loading...
Cintas
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Acuren wins in 6 metrics, Cintas wins in 11 metrics, with 0 ties. Cintas appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Acuren | Cintas | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 44.48 | 51.54 | Acuren |
| Price-to-Book Ratio | 1.02 | 19.46 | Acuren |
| Debt-to-Equity Ratio | 71.71 | 56.67 | Cintas |
| PEG Ratio | -0.08 | 48.35 | Acuren |
| EV/EBITDA | 24.97 | 34.44 | Acuren |
| Profit Margin (TTM) | -13.14% | 17.53% | Cintas |
| Operating Margin (TTM) | -3.75% | 22.40% | Cintas |
| EBITDA Margin (TTM) | N/A | 22.40% | N/A |
| Return on Equity | -19.28% | 40.27% | Cintas |
| Return on Assets (TTM) | -1.04% | 15.53% | Cintas |
| Free Cash Flow (TTM) | $73.67M | $1.76B | Cintas |
| Dividend Yield | N/A | 0.90% | N/A |
| 1-Year Return | -25.63% | 19.78% | Cintas |
| Price-to-Sales Ratio (TTM) | 1.68 | 8.82 | Acuren |
| Enterprise Value | $1.84B | $93.57B | Cintas |
| EV/Revenue Ratio | 1.66 | 9.05 | Acuren |
| Gross Profit Margin (TTM) | 18.64% | 49.71% | Cintas |
| Revenue per Share (TTM) | $13 | $26 | Cintas |
| Earnings per Share (Diluted) | $-1.25 | $4.39 | Cintas |
| Beta (Stock Volatility) | N/A | 1.02 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Acuren vs Cintas Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Acuren | -3.50% | -15.05% | -17.44% | -9.56% | -21.92% | -21.92% |
| Cintas | 1.28% | 2.15% | 5.10% | 5.26% | 10.93% | 24.26% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Acuren | -25.63% | -25.63% | 240.73% | -99.93% | -99.88% | -99.88% |
| Cintas | 19.78% | 108.43% | 186.02% | 922.92% | 3,402.63% | 1,998.98% |
Performance & Financial Health Analysis: Acuren vs Cintas
| Metric | TIC | CTAS |
|---|---|---|
| Market Information | ||
| Market Cap | $1.86B | $91.18B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 4,317,010 | 1,330,620 |
| 90 Day Avg. Volume | 2,700,947 | 1,453,517 |
| Last Close | $9.37 | $226.27 |
| 52 Week Range | $8.76 - $14.28 | $180.78 - $229.24 |
| % from 52W High | -34.38% | -1.30% |
| All-Time High | $14,700.00 (Jul 03, 2017) | $229.24 (Jun 06, 2025) |
| % from All-Time High | -99.94% | -1.30% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.08% |
| Quarterly Earnings Growth | N/A | 0.08% |
| Financial Health | ||
| Profit Margin (TTM) | -0.13% | 0.18% |
| Operating Margin (TTM) | -0.04% | 0.22% |
| Return on Equity (TTM) | -0.19% | 0.40% |
| Debt to Equity (MRQ) | 71.71 | 56.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $9.22 | $11.63 |
| Cash per Share (MRQ) | $1.27 | $0.66 |
| Operating Cash Flow (TTM) | $34.94M | $2.17B |
| Levered Free Cash Flow (TTM) | $172.22M | $1.56B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.90% |
| Last 12-Month Dividend | N/A | $2.01 |
Valuation & Enterprise Metrics Analysis: Acuren vs Cintas
| Metric | TIC | CTAS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 44.48 | 51.54 |
| Forward P/E | 30.14 | 48.35 |
| PEG Ratio | -0.08 | 48.35 |
| Price to Sales (TTM) | 1.68 | 8.82 |
| Price to Book (MRQ) | 1.02 | 19.46 |
| Market Capitalization | ||
| Market Capitalization | $1.86B | $91.18B |
| Enterprise Value | $1.84B | $93.57B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.66 | 9.05 |
| Enterprise to EBITDA | 24.97 | 34.44 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.02 |
| Book Value per Share (MRQ) | $9.22 | $11.63 |
Financial Statements Comparison: Acuren vs Cintas
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TIC | CTAS |
|---|---|---|
| Revenue/Sales | $234.22M | $2.67B |
| Cost of Goods Sold | $190.55M | $1.34B |
| Gross Profit | $43.67M | $1.33B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-8.79M | $597.45M |
| EBITDA | $20.93M | $721.36M |
| Pre-Tax Income | $-24.33M | $575.42M |
| Income Tax | $1.47M | $127.16M |
| Net Income (Profit) | $-25.79M | $448.26M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TIC | CTAS |
|---|---|---|
| Cash & Equivalents | $155.74M | $263.97M |
| Total Current Assets | $376.67M | $3.44B |
| Total Current Liabilities | $107.93M | $1.64B |
| Long-Term Debt | $784.25M | $2.60B |
| Total Shareholders Equity | $1.13B | $4.68B |
| Retained Earnings | $-132.78M | $11.80B |
| Property, Plant & Equipment | $30.52M | $3.50B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TIC | CTAS |
|---|---|---|
| Operating Cash Flow | $35.09M | $599.12M |
| Capital Expenditures | $-4.18M | $0 |
| Free Cash Flow | $28.32M | $521.13M |
| Debt Repayment | $-4.44M | $-450.00M |
| Common Stock Repurchase | N/A | $-256.67M |
Short Interest & Institutional Ownership Analysis
| Metric | TIC | CTAS |
|---|---|---|
| Shares Short | 8.45M | 5.45M |
| Short Ratio | 3.54 | 3.93 |
| Short % of Float | 0.16% | 0.02% |
| Average Daily Volume (10 Day) | 4,317,010 | 1,330,620 |
| Average Daily Volume (90 Day) | 2,700,947 | 1,453,517 |
| Shares Outstanding | 121.48M | 402.95M |
| Float Shares | 44.17M | 342.35M |
| % Held by Insiders | 0.10% | 0.15% |
| % Held by Institutions | 0.51% | 0.67% |
Dividend Analysis & Yield Comparison: Acuren vs Cintas
| Metric | TIC | CTAS |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.01 |
| Last 12-Month Dividend Yield | N/A | 0.90% |
| 3-Year Avg Annual Dividend | N/A | $1.51 |
| 3-Year Avg Dividend Yield | N/A | 0.22% |
| 3-Year Total Dividends | N/A | $4.53 |
| Ex-Dividend Date | N/A | Aug 15, 2025 |